Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $9.45 USD
Change Today +0.18 / 1.94%
Volume 163.7K
AFFX On Other Exchanges
As of 5:10 PM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

3420 Central Expressway

Santa Clara, CA 95051

United States

Phone: 408-731-5000

Fax: 408-731-5380

diversified revenue streams and a broad reach into the growing markets for translational medicine, molecular diagnostics and applied sciences, such as agricultural biotechnology (AgBio). Collaborative Partners The company works with its partners to develop and supply certain components of the user work flow that fall outside of its core competencies, but are important to its customer’s application. These companies include Danaher Corporation, Luminex Corporation, CapitalBio Corporation, Life Technologies Corporation, Genisphere LLC, Hamilton Robotics (a division of Hamilton Company), Takara Bio Inc. and New England Biolabs, Inc. The company’s PbA partners include F. Hoffman-La Roche Ltd., Veracyte Inc. GenomeDx, Ariosa Diagnostics, Skyline Diagnostics and Lineagen, amongst others. In 2014, the company established a partnership with Ariosa (part of F. Hoffman-La Roche Ltd.) to offer an array-based approach to the Non-Invasive Prenatal Testing (NIPT) market. The company also collaborates with certain academic, government, and commercial research groups to develop and validate new applications of its technologies. These include the Massachusetts Institute of Technology, Massachusetts General Hospital, Centers for Disease Control and Prevention, the National Genome Research Institute and U.K. Biobank. Research and Development The company’s research and development expenses, as of December 31, 2014, included $50.2 million. Competition The company’s competitors include Thermo Fisher; Roche Diagnostics; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; and Danaher. History Affymetrix, Inc. was founded in 1991. The company was incorporated in California in 1992 and reincorporated in Delaware in 1998.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFX:US $9.45 USD +0.18

AFFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Fluidigm Corp $10.60 USD -0.26
Foundation Medicine Inc $17.36 USD +1.03
Luminex Corp $21.90 USD +0.01
Pacific Biosciences of California Inc $10.42 USD +0.01
Takara Bio Inc ¥1,315 JPY -17.00
View Industry Companies

Industry Analysis


Industry Average

Valuation AFFX Industry Range
Price/Earnings 66.7x
Price/Sales 2.1x
Price/Book 2.3x
Price/Cash Flow 67.3x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AFFYMETRIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at